32 results on '"F.P. Russo"'
Search Results
2. The dietary supplementation with brown seaweeds and chromium picolinate improves NAFLD and NASH by modulating lipid metabolism and inflammation
3. OC.08.3 HCC RECURRENCE AFTER LIVER TRANSPLANTATION: THE VALIDATION OF RETREAT SCORE IN A SINGLE CENTER COHORT
4. Increased level of presepsin in patients with acutely decompensated cirrhosis predicts development of acute-on-chronic liver failure
5. Tyrosol attenuates hepatic steatosis and fibrosis in a mouse model of NASH
6. People with autoimmune hepatitis and celiac disease have a milder liver disease course and a better chance of immunosuppressive treatment withdrawal
7. T.07.2 THE IMPACT OF NUCLEOS(T)IDE ANALOGUES ON THE WAITING LIST
8. Recurrence of primary sclerosing cholangitis after liver transplantation: A single center data
9. Hepatitis D: A still relevant disease
10. Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic Hepatitis C aged 75 years or older: A multicenter study
11. Quality of life outcomes in people with Primary Biliary Cholangitis treated with obeticholic acid: results of a phase 4 real life observational trial
12. Persistent biochemical alteration at one year can lead to worse clinical outcomes in autoimmune hepatitis
13. Surveillance of hepatobiliary cancers in primary sclerosing cholangitis: a preliminary study on the role of PET-MRI
14. Epidemiological, virological and clinical profile of HBsAg positive individuals in Italian hospital settings: interim results of the HBV/HDV PITER cohort
15. Increased platelet aggregation in decompensated cirrhosis indicates higher risks of further decompensation and liver-related mortality
16. De-novo occurrence of portal vein thrombosis in patients with HCV-related cirrhosis after sustained virological response: medium to long term observations from the ongoing PITER cohort
17. OC.13.5 BMI AND COLORECTAL CANCER: A TEN-YEAR EXPERIENCE IN A GASTROENTEROLOGY UNIT IN NORTHEAST ITALY
18. T.08.6 CIRCULATING MICRORNA-21 AND HIF-1ALPHA IN CHRONIC LIVER DISEASES AND HEPATOCELLULAR CARCINOMA
19. Role of immune activation and senescent profile as prognostic markers for cancer onset in patients undergoing liver transplantation
20. Investigating the effect of gender on liver fibrosis and associated sarcopenia
21. Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression
22. The role of immune profile in patients with severe alcoholic hepatitis in predicting mortality and the development of infections: a prospective evaluation
23. De novo neoplasms after liver transplantation: donor gender and age influence
24. Steatosis in patients with HCV chronic liver disease: Baseline results from patients enrolled in the PITER cohort study
25. P.10.8 PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE
26. Circulating microparticles and risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma
27. La tecnica DPAA (Deep Proton Activation Analysis): un innovativo metodo per la caratterizzazione del corpo di monete antiche
28. Bleeding-unrelated mortality is not increased in patients with cirrhosis and ascites on treatment with β-blockers: A meta-analysis
29. F.N.48 INFLUENCE OF DONOR–RECIPIENT VARIABLES ON SHORT TERM PATIENT SURVIVAL FOLLOWING LIVER TRANSPLANTATION (LT)
30. PO.24 NO EVIDENCE OF LIVER FIBROSIS IMPROVEMENT AFTER BONE MARROW STEM CELL THERAPY IN A CCL4 MURINE MODEL OF LIVER INJURY
31. Expression of Matrix Metalloproteinases and Their Specific Inhibitors in Normal and Different Human Thyroid Tumor Cell Lines.
32. Terapia cellulare in Epatologia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.